Mechanism of development and progression in prostate cancer: Overview
Teishima, J.; Matsubara, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 80-86
2016
ISSN/ISBN: 0047-1852 PMID: 27344708 Document Number: 686407
Document emailed within 1 workday
Related Documents
Jenster, G. 1999: The role of the androgen receptor in the development and progression of prostate cancer Seminars in Oncology 26(4): 407-421Shimazaki, J. 1998: Development and progression of prostate cancer in relation with androgen dependency Nihon Rinsho. Japanese Journal of Clinical Medicine 56(8): 1953-1958
Goya, M.; Yonou, H.; Saito, S. 2011: Mechanism of the development of osteoblastic bone metastasis of prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 5): 638-644
Murray, N.P.; Aedo, S.óc.; Fuentealba, C.; Reyes, E.; Minzer, S.; Salazar, A.íb. 2019: Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer Archivos Espanoles de Urologia 72(5): 471-482
Mocarska, A.; Czarnocki, K.; Starosławska, E.; Janczarek, M.; Zelazowska-Cieslińska, I.; Losicki, M.; Burdan, F. 2014: Evaluation of prostate cancer progression Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 37(222): 356-364
Newling, D.W. 1990: Parameters of response and progression in prostate cancer Progress in Clinical and Biological Research 359: 25-48; Discussion: 73-74
Bissada, N.K. 2000: Prostate cancer: an overview Journal of the South Carolina Medical Association 96(2): 52
Vacherot, F.; Terry, Séphane.; Faucon, H.; Queires, L.; Chen, M-Wei.; Yang, X.; Gil Diez de Medina, S.; Verdier, A.; Azoulay, S.; Allory, Y.; Abbou, C.C.; Buttyan, R.; de la Taille, A. 2005: Protocadherin-PC discovery and its implication in prostate cancer progression Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 15(6 Suppl. 1): 1294-1302
Kanoh, Y.; Mashiko, T.; Danbara, M.; Takayama, Y.; Ohtani, S.; Egawa, S.; Baba, S.; Akahoshi, T. 2004: Changes in serum IgG oligosaccharide chains with prostate cancer progression Anticancer Research 24(5b): 3135-3139
Feng, W.; Zhang, H.-b.; Wang, Y.-m.; Hu, J.-l. 2015: Correlation of FOXA1 with the malignancy and progression of prostate cancer Zhonghua Nan Ke Xue 21(5): 414-419
Giannakopoulos, X.; Stagikas, D.; Peschos, D.; Batistatou, A.; Charalabopoulos, K. 2007: Implication of protocadherin-PC in the progression of the advanced prostate cancer Experimental Oncology 29(1): 74-75
Strief, D.M. 2007: An overview of prostate cancer: diagnosis and treatment Urologic Nursing 27(6): 475-479; Quiz 480
Baltogiannis, D.; Giannakopoulos, X.; Charalabopoulos, K.; Sofikitis, N. 2004: Monotherapy in advanced prostate cancer: an overview Experimental Oncology 26(3): 185-191
Parsons, J.K.; Marshall, J.R.; Nelson, H. 2013: Does altering diet affect progression of prostate cancer? the MEAL study Bulletin of the American College of Surgeons 98(10): 57-59
Spanjol, J.; Maricić, A.; Valencić, M.; Oguić, R.; Krpina, K.; Protić, A.; Ivancić, A.; Bobinac, M.; Fuckar, D.; Vojniković, B. 2008: Influence of insolation on osteoporosis progression in androgen deprived nonmetastatic prostate cancer patients Collegium Antropologicum 32(Suppl 2): 79-81
Lokeshwar, V.B.; Lokeshwar, B.L.; Pham, H.T.; Block, N.L. 1996: Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression Cancer Research 56(3): 651-657
Yamada, Y.; Fujiwara, H.; Somiya, S.; Fujikawa, S.; Kamiyama, Y.; Tamaki, M.; Kanaoka, T. 2018: Delay in High-Grade Metastatic Prostate Cancer Progression by Dutasteride : A Case Report Hinyokika Kiyo. Acta Urologica Japonica 64(4): 187-192
Sakamoto, S.; Ichikawa, T. 2014: Mechanism of prostate cancer invasion and metastasis Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2086-2089
Almeras, C.; Zerbib, M.; Eschwege, F.ço.; Debré, B. 2002: Nadir PSA and kinetics of PSA decline between the 3rd and 6th month after external beam radiotherapy for T1 T2 Nx M0 localized prostate cancer: value of the prediction of the risk of biological progression Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 12(2): 219-225
Lee, J.; Wang, A.; Hu, Q.; Lu, S.; Dong, Z. 2006: Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice International Journal of Oncology 29(6): 1405-1412